Article Sidebar
Main Article Content
Abstract
Background: En coup de sabre (ECDS) is one of the clinical variations of morphea. ECDS refers to a variant of linear morphea that usually involves the forehead and frontal scalp that may be associated with alopecia. This study aimed to describe a case of en coup de sabre with its diagnosis and management.
Case presentation: A girl, aged 16 years, came to the dermatology polyclinic with the main complaint of a sunken brown spot on the left forehead and corner of the left eye, which has been expanding since 2 months ago. This complaint does not feel itchy or painful, but because it is getting more widespread, patients feel embarrassed and often cover it up. On dermatological examination, depressed hyperpigmented macules, plaque size, firm boundaries, and location on the left medial superior lid and left medial glabella were found. On dermoscopy examination, a reticular pigment network obliterating the follicular opening was found. The results of the histopathological examination showed the impression of a linear morphea type with en coup de sabre. This patient was diagnosed with linear morphea type with en coup de sabre
Conclusion: En coup de sabre is a rare autoimmune disorder and is a subtype of morphea. Early detection and appropriate intervention will reduce disease progression.
Keywords
Article Details
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
